Data from preclinical tests are indispensable for making decisions on efficacy and safety. The information won as a result of these tests plays a key role for all subsequent choices. However, to perform preclinical active agent development as successfully as possible, preclinical models that reflect the patient’s situation with high precision are needed. For this reason aside from other innovative approaches, Fraunhofer Group for Life Sciences is also focusing on the development of human 3D-test models as well as live tissue sections. Find out more about the broad spectrum of preclinical models that we have developed.